U

Universe Pharmaceuticals Inc
NASDAQ:UPC

Watchlist Manager
Universe Pharmaceuticals Inc
NASDAQ:UPC
Watchlist
Price: 4.09 USD -1.68% Market Closed
Market Cap: 2.3m USD

Universe Pharmaceuticals Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Universe Pharmaceuticals Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
U
Universe Pharmaceuticals Inc
NASDAQ:UPC
EPS (Diluted)
-$626
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
EPS (Diluted)
ÂĄ0
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
EPS (Diluted)
ÂĄ4
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
EPS (Diluted)
ÂĄ1
CAGR 3-Years
26%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
EPS (Diluted)
ÂĄ2
CAGR 3-Years
25%
CAGR 5-Years
-5%
CAGR 10-Years
1%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
EPS (Diluted)
ÂĄ9
CAGR 3-Years
N/A
CAGR 5-Years
241%
CAGR 10-Years
N/A
No Stocks Found

Universe Pharmaceuticals Inc
Glance View

Market Cap
2.3m USD
Industry
Pharmaceuticals

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 263 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.

UPC Intrinsic Value
38.51 USD
Undervaluation 89%
Intrinsic Value
Price
U

See Also

What is Universe Pharmaceuticals Inc's EPS (Diluted)?
EPS (Diluted)
-627 USD

Based on the financial report for Sep 30, 2024, Universe Pharmaceuticals Inc's EPS (Diluted) amounts to -627 USD.

What is Universe Pharmaceuticals Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
42%

Over the last year, the EPS (Diluted) growth was 42%.

Back to Top